Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen -- Ignore unavailable to you. Want to Upgrade?

To: Vector1 who wrote (543)	1/16/1998 3:57:00 PM
From: scaram(o)uche	Read Replies (2) \| Respond to of 1686

V1: Note that IMNX was also very vocal about being aggressive with the molecule itself, CD40L. As I've indicated, the preclinical data and my own experience with the Noelle antibody tells me that anti-CD40L is going to be huge. I can think of a few companies that, IMO, will be great short candidates in about 18 months. Lurking reporter: It's time that you start to give direct attribution rather than picking up leads here (or face-to-face), pursuing independent verification and commentary, and going to print. You are violating the "open exchange" spirit of SI. Rick